PFM Health Sciences’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,301,942
| Closed | -$3.6M | – | 68 |
|
|
2025
Q1 | $3.6M | Buy |
3,301,942
+1,222,697
| +59% | +$1.33M | 0.26% | 44 |
|
|
2024
Q4 | $3.14M | Buy |
2,079,245
+68,205
| +3% | +$103K | 0.19% | 54 |
|
|
2024
Q3 | $3M | Buy |
2,011,040
+735,578
| +58% | +$1.1M | 0.17% | 60 |
|
|
2024
Q2 | $2.07M | Hold |
1,275,462
| – | – | 0.1% | 65 |
|
|
2024
Q1 | $2.17M | Sell |
1,275,462
-197,551
| -13% | -$336K | 0.1% | 77 |
|
|
2023
Q4 | $4.57M | Buy |
1,473,013
+177,909
| +14% | +$552K | 0.27% | 53 |
|
|
2023
Q3 | $7.95M | Buy |
1,295,104
+1,066,694
| +467% | +$6.55M | 0.37% | 56 |
|
|
2023
Q2 | $1.43M | Sell |
228,410
-189,617
| -45% | -$1.19M | 0.06% | 75 |
|
|
2023
Q1 | $1.99M | Buy |
418,027
+84,311
| +25% | +$402K | 0.09% | 68 |
|
|
2022
Q4 | $2.9M | Sell |
333,716
-521,448
| -61% | -$4.54M | 0.1% | 66 |
|
|
2022
Q3 | $10.2M | Sell |
855,164
-359,000
| -30% | -$4.27M | 0.37% | 59 |
|
|
2022
Q2 | $17.3M | Buy |
1,214,164
+767,864
| +172% | +$10.9M | 0.66% | 49 |
|
|
2022
Q1 | $9.29M | Buy |
446,300
+157,966
| +55% | +$3.29M | 0.35% | 54 |
|
|
2021
Q4 | $6.66M | Hold |
288,334
| – | – | 0.23% | 59 |
|
|
2021
Q3 | $8.59M | Hold |
288,334
| – | – | 0.25% | 58 |
|
|
2021
Q2 | $9.85M | Buy |
+288,334
| New | +$9.85M | 0.31% | 60 |
|